A detailed history of Bell Investment Advisors, Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 121 shares of RDY stock, worth $9,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Previous 63 92.06%
Holding current value
$9,442
Previous $4,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$67.36 - $77.59 $3,906 - $4,500
58 Added 92.06%
121 $8,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $449 - $489
7 Added 12.5%
63 $4,000
Q3 2023

Nov 08, 2023

BUY
$61.9 - $72.77 $1,671 - $1,964
27 Added 93.1%
56 $3,000
Q2 2023

Aug 09, 2023

BUY
$53.34 - $63.11 $1,013 - $1,199
19 Added 190.0%
29 $1,000
Q1 2023

May 10, 2023

SELL
$51.63 - $56.93 $516 - $569
-10 Reduced 50.0%
10 $0
Q4 2022

Feb 08, 2023

BUY
$51.15 - $57.45 $1,023 - $1,149
20 New
20 $1,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $13B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.